Blog
RSS FeedPosted by Michael Wonder on 28 Feb 2022
Prescription medicines: applications under evaluation (February 2022)
25 February 2022 - The TGA has updated its list of applications for new medicines or new uses for existing ...
Posted by Michael Wonder on 25 Feb 2022
TGA provisionally approves AstraZeneca's combination therapy (tixagevimab and cilgavimab, Evusheld) - for pre-exposure prevention (prophylaxis) of COVID-19
25 February 2022 - On 24 February 2022, the TGA granted provisional approval to AstraZeneca for its tixagevimab and cilgavimab ...
Posted by Michael Wonder on 24 Feb 2022
COVID-19 vaccine weekly safety report (24 February 2022)
24 February 2022 - To 20 February 2022, the TGA has received 451 reports which have been assessed as likely to ...
Posted by Michael Wonder on 24 Feb 2022
ATAGI recommendations on the use of Spikevax (Moderna) COVID-19 vaccine in children aged 6 to 11 years
23 February 2022 - The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for the use of the Moderna ...
Posted by Michael Wonder on 23 Feb 2022
TGA checks need for another vax booster
23 February 2022 - Australia is looking at whether to offer a fourth COVID dose ahead of the flu season ...
Posted by Michael Wonder on 23 Feb 2022
‘Grumpy’ TGA boss unloads over people downplaying COVID’s effect on kids
23 February 2022 - The head of Australia’s medicines regulator has unloaded on those downplaying the effect COVID-19 has on ...
Posted by Michael Wonder on 22 Feb 2022
Controversial Alzheimer’s drug under TGA review ‘should not be approved’
21 February 2022 - Patients will be put at risk and taxpayers will face a significant economic burden if aducanumab receives ...
Posted by Michael Wonder on 22 Feb 2022
TGA approves Rybelsus
22 February 2022 - Rybelsus is a new formulation of semaglutide. ...
Posted by Michael Wonder on 17 Feb 2022
COVID-19 vaccine weekly safety report (17 February 2022)
17 February 2022 - To 13 February 2022, the TGA has received 449 reports which have been assessed as likely to ...
Posted by Michael Wonder on 17 Feb 2022
Empaveli approved by the TGA
17 February 2022 - First TGA approval for newcomer Apellis. ...
Posted by Michael Wonder on 16 Feb 2022
Moderna's COVID-19 vaccine (Spikevax) provisionally approved for use in individuals 6 years and older
17 February 2022 - The TGA has provisionally approved the Moderna COVID-19 vaccine, Spikevax, for use in individuals aged 6 ...
Posted by Michael Wonder on 14 Feb 2022
Anxiety mounts for Australian patients as supply chain crunch hits another arthritis drug
14 February 2022 - Patients are reckoning with major shortages of a second rheumatoid arthritis drug in Australia, with manufacturing ...
Posted by Michael Wonder on 11 Feb 2022
New advice to keep Australians ‘up to date’ with COVID-19 vaccinations
10 February 2022 - The Australian Government has today received updated advice from the medical experts of the Australian Technical Advisory ...
Posted by Michael Wonder on 10 Feb 2022
Patent box legislation to promote Australian innovation
11 February 2022 - Medicines Australia notes the introduction of patent box legislation, Treasury Laws Amendment (Tax Concession for Australian ...
Posted by Michael Wonder on 10 Feb 2022
Three doses to be ‘up to date’ as national cabinet prepares for winter waves
10 February 2022 - Top Australian health officials now say people need a third coronavirus vaccine dose to be considered up ...